WeVote
Log In

Bill

Bill

HB 830

Pharmacy benefits managers; requirements, application of law, report, delayed effective date.

2026 Regular Session Introduced by Bonita Anthony and 20 co-sponsors

Virginia HB 830 requires pharmacy benefits managers to meet new transparency and reporting standards, increasing regulatory oversight of drug pricing and reimbursement practices affecting consumers and pharmacies.

Acts of Assembly Chapter text (CHAP0678)
0
WeVote Research Nonpartisan
Bill Summary · HB 830

Legislative bill overview

HB 830 establishes new regulatory requirements and reporting obligations for pharmacy benefits managers (PBMs) operating in Virginia. The bill aims to increase transparency and oversight of PBM practices that affect drug pricing, pharmacy reimbursement, and consumer costs.

Why is this important

PBMs function as intermediaries between insurers, pharmacies, and drug manufacturers, controlling which drugs are covered and at what price. Their practices significantly impact medication affordability for consumers and profitability for pharmacies, making regulatory oversight a substantive healthcare policy issue affecting millions of Virginians.

Potential points of contention

  • Industry pushback on compliance costs: PBMs may argue that new reporting requirements impose significant administrative burdens and costs that could be passed to consumers or reduce service availability
  • Scope of regulatory authority: Questions about whether Virginia can effectively regulate PBMs operating across multiple states and whether federal preemption limits state action
  • Definition and enforcement gaps: Ambiguity over what specific practices are being restricted and how violations will be investigated and penalized could limit the bill's practical effectiveness

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.